These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27878737)

  • 1. Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency.
    Frampton JE
    Am J Cardiovasc Drugs; 2016 Dec; 16(6):461-468. PubMed ID: 27878737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies.
    Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA
    Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study.
    Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M
    J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.
    Jones SA; Rojas-Caro S; Quinn AG; Friedman M; Marulkar S; Ezgu F; Zaki O; Gargus JJ; Hughes J; Plantaz D; Vara R; Eckert S; Arnoux JB; Brassier A; Le Quan Sang KH; Valayannopoulos V
    Orphanet J Rare Dis; 2017 Feb; 12(1):25. PubMed ID: 28179030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
    Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
    J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency.
    Paton DM
    Drugs Today (Barc); 2016 May; 52(5):287-93. PubMed ID: 27376161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review.
    Bashir A; Tiwari P; Duseja A
    Ther Adv Rare Dis; 2021; 2():26330040211026928. PubMed ID: 37181111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sebelipase alfa: first global approval.
    Shirley M
    Drugs; 2015 Nov; 75(16):1935-40. PubMed ID: 26452566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency.
    Wilson DP; Friedman M; Marulkar S; Hamby T; Bruckert E
    J Clin Lipidol; 2018; 12(3):604-614. PubMed ID: 29628368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension study.
    Malinová V; Balwani M; Sharma R; Arnoux JB; Kane J; Whitley CB; Marulkar S; Abel F
    Liver Int; 2020 Sep; 40(9):2203-2214. PubMed ID: 32657505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal acid lipase deficiency allograft recurrence and liver failure- clinical outcomes of 18 liver transplantation patients.
    Bernstein DL; Lobritto S; Iuga A; Remotti H; Schiano T; Fiel MI; Balwani M
    Mol Genet Metab; 2018 May; 124(1):11-19. PubMed ID: 29655841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.
    Valayannopoulos V; Malinova V; Honzík T; Balwani M; Breen C; Deegan PB; Enns GM; Jones SA; Kane JP; Stock EO; Tripuraneni R; Eckert S; Schneider E; Hamilton G; Middleton MS; Sirlin C; Kessler B; Bourdon C; Boyadjiev SA; Sharma R; Twelves C; Whitley CB; Quinn AG
    J Hepatol; 2014 Nov; 61(5):1135-42. PubMed ID: 24993530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.
    Balwani M; Breen C; Enns GM; Deegan PB; Honzík T; Jones S; Kane JP; Malinova V; Sharma R; Stock EO; Valayannopoulos V; Wraith JE; Burg J; Eckert S; Schneider E; Quinn AG
    Hepatology; 2013 Sep; 58(3):950-7. PubMed ID: 23348766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
    Maciejko JJ
    Am J Cardiovasc Drugs; 2017 Jun; 17(3):217-231. PubMed ID: 28197978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.
    Ezgü F
    Expert Opin Drug Saf; 2022 Feb; 21(2):149-155. PubMed ID: 34664536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal acid lipase deficiency: Expanding differential diagnosis.
    Valayannopoulos V; Mengel E; Brassier A; Grabowski G
    Mol Genet Metab; 2017; 120(1-2):62-66. PubMed ID: 27876313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: Two infants treated with sebelipase alfa.
    Santos Silva E; Klaudel-Dreszler M; Bakuła A; Oliva T; Sousa T; Fernandes PC; Tylki-Szymańska A; Kamenets E; Martins E; Socha P
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):e77-e82. PubMed ID: 29705274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.
    Burton BK; Balwani M; Feillet F; Barić I; Burrow TA; Camarena Grande C; Coker M; Consuelo-Sánchez A; Deegan P; Di Rocco M; Enns GM; Erbe R; Ezgu F; Ficicioglu C; Furuya KN; Kane J; Laukaitis C; Mengel E; Neilan EG; Nightingale S; Peters H; Scarpa M; Schwab KO; Smolka V; Valayannopoulos V; Wood M; Goodman Z; Yang Y; Eckert S; Rojas-Caro S; Quinn AG
    N Engl J Med; 2015 Sep; 373(11):1010-20. PubMed ID: 26352813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Lysosomal Acid Lipase Deficiency Confirmed by Response to Sebelipase Alfa Therapy.
    Shen JJ; Davis JL; Hong X; Laningham FH; Gelb MH; Kim GE
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):726-730. PubMed ID: 32740531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa.
    Su K; Donaldson E; Sharma R
    Appl Clin Genet; 2016; 9():157-167. PubMed ID: 27799810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.